Skip To Content
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Before it's here, it's on the Bloomberg Terminal.
Learn More
6620:TTTaipei

Handa Pharmaceuticals Inc

COMPANY INFO
30.50TWD
Market Closed
As of 08/15/2019 EDT
Open
31.14
Prev Close
30.50
Volume
3,254
Market Cap
3.198B
Day Range
30.5031.14
52 Week Range
16.1940.34
1D1M1Y5Y
View Full Chart
Market Closed
As of 08/15/2019 EDT
1D1M1Y5Y
View Full Chart
markets
Walmart Jumps Most in a Year on Strong 2Q Sales
Before it's here, it's on the Bloomberg Terminal.
Learn More
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.

Key Statistics

P/E Ratio--
Bloomberg (BEst) P/E Ratio--
Bloomberg (BEst) PEG Ratio--
Shares Outstanding104.71M
Price to Book Ratio4.7236
Price to Sales Ratio31.2275
1 Year Return13.97%
30 Day Avg Volume5,522
EPS-1.35
Bloomberg (BEst) EPS Curr Yr--
Dividend--
Last Dividend Reported--

About Handa Pharmaceuticals Inc

Handa Pharmaceuticals, Inc. is a drug development company. The Company researches, develops, and markets pharmaceutical patents niche products. Handa Pharmaceuticals serves customers worldwide.
Address
3F-1, 3F-2, No 23, Nanke 3rd R Xinshi District Tainan City, 74147 Taiwan
Phone
886-6-505-7508
Website
www.handapharma.com.tw

Income Statement

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions TWD)
  • Revenue
    --
  • Net Income
    --
  • Profit Margin
    --%

Balance Sheet

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions TWD)
  • Total Assets
    --
  • Total Liabilities
    --
  • Debt to Assets
    --%

Cash Flow

Quarterly
Annual
Sorry, no quarterly data is available at this time.
Q3 2019 (Millions TWD)
  • Operating
    --
  • Investing
    --
  • Financing
    --